对血清素-2A受体 (5-HT2AR) 调节器差异性作用的分子动力学研究
Jordy Peeters1, Dimitri De Bundel2, Kenno Vanommeslaeghe1
1Department of Analytical Chemistry, Applied Chemometrics and Molecular Modelling (FABI), Vrije Universiteit Brussel (VUB), Brussels, Belgium.
PLoS computational biology
|September 3, 2025
概括
适度激活血清素-2A受体 (5-HT2AR) 可能在没有幻觉的情况下提供抗抑郁药的好处. 然而过度激活会导致幻觉,
科学领域:
- 神经科学
- 药理学
- 计算化学
背景情况:
- 血清素-2A受体 (5-HT2AR) 是新型抗抑郁药的主要点,特别是在迅速发作或耐治疗的抑郁症中.
- 一个主要的障碍是与5-HT2AR激活相关的幻觉潜力.
- 部分激动剂正在研究抗抑郁作用而没有心理仿效副作用.
研究的目的:
- 阐明由各种配体引起的差异性5-HT2AR激活的原子机制.
- 为了确定5-HT2AR的依赖联体的构造.
- 了解抗抑郁药对幻觉的影响的结构性基础.
主要方法:
- 在5-HT2AR上进行了原子分子动力学 (MD) 模拟.
- 模拟包括抗精神病药物,潜在的非幻觉剂和幻觉剂的结合.
- 分析了联结受体的结构.
主要成果:
- 结果表明,适度的5-HT2AR激活与抗抑郁作用相关.
- 幻觉似乎是受体过度激活的结果.
- 确定了不同的依赖体的形状.
结论:
- 适度的5-HT2AR激活可能为抑郁症提供治疗效益.
- 过度激活会导致幻觉,
- 弱部分激动剂为更安全的抗抑郁药提供了潜在的药物开发策略.
相关概念视频
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
395
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
395
Antidepressant Drugs: MAOIs and Other Agents
340
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
340
Drugs Affecting Neurotransmitter Release or Uptake
1.2K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.2K
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
3.3K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.3K
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
563
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
563
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
293
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
293


